Confronto
Icatibant vs. Teduglutid
Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.
Identità
Categoria
Ricerca (altro)
Ricerca (altro)
N. CAS
138614-30-9
197922-42-2
Peso molecolare
1304.52 g/mol
3752.13 g/mol
Emivita
nessun dato
nessun dato
Sequenza
nessun dato
nessun dato
Meccanismo d'azione
Icatibant
Icatibant competitively blocks the bradykinin B2 receptor. Because bradykinin mediates the vascular permeability, swelling and pain typical of hereditary angioedema, the blockade interrupts the acute attack.
Teduglutid
Teduglutide activates the GLP-2 receptor, promoting growth and regeneration of small-intestinal villi, increasing nutrient and fluid absorption and thereby reducing dependence on parenteral nutrition. The glycine substitution at position 2 makes it resistant to rapid breakdown by DPP-4.
Base di evidenze
Evidenza più alta
RCT sull'uomo
RCT sull'uomo
Studi
1
2
di cui sull'uomo
1
2
Effetti registrati
1
2
Contraddizioni aperte
0
0
Eventi avversi documentati
1
2
Stato legale
Voci complete
Frequently asked questions
- What is the difference between Icatibant and Teduglutid?
- Icatibant is classified as "Ricerca (altro)", while Teduglutid is classified as "Ricerca (altro)". Icatibant: Icatibant is a synthetic decapeptide and selective antagonist of the bradykinin B2 receptor. It is approved to treat acute attacks of hereditary angioedema (HAE). Teduglutid: Teduglutide is a DPP-4-resistant analog of GLP-2 (glucagon-like peptide-2). It promotes growth and function of the intestinal mucosa and is approved for treating short bowel syndrome. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Icatibant or Teduglutid?
- The highest available evidence level is "RCT sull'uomo" for Icatibant and "RCT sull'uomo" for Teduglutid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Icatibant and Teduglutid in Germany and the United States?
- Germania: Icatibant — Su prescrizione, Teduglutid — Su prescrizione. Stati Uniti: Icatibant — Su prescrizione, Teduglutid — Su prescrizione. These are factual summaries with source and review date on the individual pages.